Log in to save to my catalogue

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04268845v1

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

About this item

Full title

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

Publisher

New York: Nature Publishing Group US

Journal title

Nature immunology, 2022-02, Vol.23 (2), p.262-274

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Tumors poorly infiltrated by T cells are more resistant to immunogenic chemotherapies and checkpoint inhibition than highly infiltrated tumors. Using murine models, we found that CCR6
+
type 3 innate lymphoid cells (ILC3s) can trigger an increase in the number of T cells infiltrating a tumor. Shortly after administration of cisplatin chemothe...

Alternative Titles

Full title

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04268845v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04268845v1

Other Identifiers

ISSN

1529-2908

E-ISSN

1529-2916

DOI

10.1038/s41590-021-01120-y

How to access this item